Acorda Therapeutics, Inc. (ACOR) PT Lowered to $28 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Raghuram Selvaraju lowered the price target on Acorda Therapeutics, Inc. (NASDAQ: ACOR) to $28.00 (from $31.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
